DOCSLIB.ORG

Download (PDF)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download (PDF) Circulation Journal Supplementary File Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Circ J 2016; 80: 2327 – 2335 The Current Status of Cardiovascular Medicine in Japan – Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC – Satoshi Yasuda, MD, PhD; Kazuhiro Nakao, MD; Kunihiro Nishimura, MD, PhD; Yoshihiro Miyamoto, MD, PhD; Yoko Sumita; Toshiaki Shishido, MD, PhD; Toshihisa Anzai, MD, PhD; Hiroyuki Tsutsui, MD, PhD; Hiroshi Ito, MD, PhD; Issei Komuro, MD, PhD; Yoshihiko Saito, MD, PhD; Hisao Ogawa, MD, PhD on the behalf of JROAD Investigators ——— Supplementary File 1 ——— Table S1. Diagnosis Codes for Data Extraction in JROAD- I220 Subsequent STEMI of anterior wall DPC I221 Subsequent STEMI of inferior wall ICD10 code Diagnosis I228 Subsequent STEMI of other site I050 Rheumatic mitral stenosis I229 Subsequent STEMI of unspecified site I051 Rheumatic mitral insufficiency I230 Hemopericardium as current complication follow- ing AMI I052 Rheumatic mitral stenosis with insufficiency I231 Atrial septal defect as current complication follow- I058 Other rheumatic mitral valve diseases ing AMI I059 Rheumatic mitral valve disease, unspecified I232 Ventricular septal defect as current complication I060 Rheumatic aortic stenosis following AMI I061 Rheumatic aortic insufficiency I233 Rupture of cardiac wall without hemopericardium I062 Rheumatic aortic stenosis with insufficiency as current complication following AMI I068 Other rheumatic aortic valve diseases I234 Rupture of chordae tendineae as current compli- cation following AMI I069 Rheumatic aortic valve disease, unspecified I235 Rupture of papillary muscle as current complica- I070 Rheumatic tricuspid stenosis tion following AMI I071 Rheumatic tricuspid insufficiency I236 Thrombosis of atrium, auricular appendage, and I072 Rheumatic tricuspid stenosis and insufficiency ventricle as current complications following AMI I078 Other rheumatic tricuspid valve diseases I238 Other current complications following AMI I079 Rheumatic tricuspid valve disease, unspecified I240 Acute coronary thrombosis not resulting in I080 Rheumatic disorders of both mitral and aortic myocardial infarction valves I241 Dressler’s syndrome I081 Rheumatic disorders of both mitral and tricuspid I248 Other forms of acute ischemic heart disease valves I249 Acute ischemic heart disease, unspecified I082 Rheumatic disorders of both aortic and tricuspid I250 Atherosclerotic heart disease of native coronary valves artery I083 Combined rheumatic disorders of mitral, aortic I251 Atherosclerotic heart disease of native coronary and tricuspid valves artery I088 Other rheumatic multiple valve diseases I252 Old myocardial infarction I089 Rheumatic multiple valve disease, unspecified I253 Aneurysm of heart I090 Rheumatic myocarditis I254 Coronary artery aneurysm and dissection I091 Rheumatic diseases of endocardium, valve I255 Ischemic cardiomyopathy unspecified I256 Silent myocardial ischemia I092 Chronic rheumatic pericarditis I258 Other forms of chronic ischemic heart disease I200 Unstable angina I259 Chronic ischemic heart disease, unspecified I201 Angina pectoris with documented spasm I340 Nonrheumatic mitral (valve) insufficiency I208 Other forms of angina pectoris I341 Nonrheumatic mitral (valve) prolapse I209 Angina pectoris, unspecified I342 Nonrheumatic mitral (valve) stenosis I210 STEMI of anterior wall I348 Other nonrheumatic mitral valve disorders I211 STEMI of inferior wall I349 Nonrheumatic mitral valve disorder, unspecified I212 STEMI of other sites I350 Nonrheumatic aortic (valve) stenosis I213 STEMI of unspecified site I351 Nonrheumatic aortic (valve) insufficiency I214 NSTEMI I219 STEMI, unspecified (Table S1 continued the next page.) Circulation Journal Vol.80, November 2016 I352 Nonrheumatic aortic (valve) stenosis with insuffi- I512 Rupture of papillary muscle, not elsewhere classi- ciency fied I358 Other nonrheumatic aortic valve disorders I513 Intracardiac thrombosis, not elsewhere classified I359 Nonrheumatic aortic valve disorder, unspecified I514 Myocarditis, unspecified I360 Nonrheumatic tricuspid (valve) stenosis I515 Myocardial degeneration I361 Nonrheumatic tricuspid (valve) insufficiency I516 CVD, unspecified I362 Nonrheumatic tricuspid (valve) stenosis with I517 Cardiomegaly insufficiency I518 Other ill-defined heart diseases I368 Other nonrheumatic tricuspid valve disorders I519 Heart disease, unspecified I369 Nonrheumatic tricuspid valve disorder, unspecified I520 Other heart disorders in bacterial diseases classi- I370 Nonrheumatic pulmonary valve stenosis fied elsewhere I371 Nonrheumatic pulmonary valve insufficiency I521 Other heart disorders in other infectious and I372 Nonrheumatic pulmonary valve stenosis with parasitic diseases classified elsewhere insufficiency I528 Other heart disorders in other diseases classified I378 Other nonrheumatic pulmonary valve disorders elsewhere I379 Nonrheumatic pulmonary valve disorder, unspeci- I710 Dissection of aorta [any part] fied I711 Thoracic aortic aneurysm, ruptured I38 Endocarditis, valve unspecified I712 Thoracic aortic aneurysm, without mention of I390 Mitral valve disorders in diseases classified else- rupture where I713 Abdominal aortic aneurysm, ruptured I391 Aortic valve disorders in diseases classified else- I714 Abdominal aortic aneurysm, without mention of where rupture I392 Tricuspid valve disorders in diseases classified I715 Thoracoabdominal aortic aneurysm, ruptured elsewhere I716 Thoracoabdominal aortic aneurysm, without I393 Pulmonary valve disorders in diseases classified mention of rupture elsewhere I718 Aortic aneurysm of unspecified site, ruptured I394 Multiple valve disorders in diseases classified I719 Aortic aneurysm of unspecified site, without elsewhere mention of rupture I398 Endocarditis, valve unspecified, in diseases clas- I720 Aneurysm and dissection of carotid artery sified elsewhere I722 Aneurysm and dissection of renal artery I420 Dilated cardiomyopathy I723 Aneurysm and dissection of iliac artery I421 Obstructive hypertrophic cardiomyopathy I724 Aneurysm and dissection of artery of lower I422 Other hypertrophic cardiomyopathy extremity I423 Endomyocardial (eosinophilic) disease I728 Aneurysm and dissection of other specified arter- I424 Endocardial fibroelastosis ies I425 Other restrictive cardiomyopathy I730 Raynaud syndrome I426 Alcoholic cardiomyopathy I731 Thromboangiitis obliterans [Buerger] I427 Cardiomyopathy due to drugs and other external I800 Phlebitis and thrombophlebitis of superficial agents vessels of lower extremities I431 Cardiomyopathy in metabolic diseases I801 Phlebitis and thrombophlebitis of femoral vein I438 Cardiomyopathy in other diseases classified else- I802 Phlebitis and thrombophlebitis of other deep where vessels of lower extremities I441 Atrioventricular block, second degree I803 Phlebitis and thrombophlebitis of lower extremi- I442 Atrioventricular block, complete ties, unspecified I443 Other and unspecified atrioventricular block I808 Phlebitis and thrombophlebitis of other sites I447 Left bundle-branch block, unspecified I809 Phlebitis and thrombophlebitis of unspecified site I460 Cardiac arrest with successful resuscitation I821 Thrombophlebitis migrans I461 Sudden cardiac death, so described I822 Embolism and thrombosis of vena cava I469 Cardiac arrest, unspecified I823 Embolism and thrombosis of renal vein I470 Re-entry ventricular arrhythmia I828 Embolism and thrombosis of other specified veins I471 Supraventricular tachycardia I829 Embolism and thrombosis of unspecified vein I472 Ventricular tachycardia I830 Varicose veins of lower extremities with ulcer I479 Paroxysmal tachycardia, unspecified I831 Varicose veins of lower extremities with inflam- mation I48 Atrial fibrillation and flutter I832 Varicose veins of lower extremities with both I490 Ventricular fibrillation and flutter ulcer and inflammation I495 Sick sinus syndrome I839 Varicose veins of lower extremities without ulcer I500 Congestive HF or inflammation I501 Left ventricular failure M303 Mucocutaneous lymph node syndrome [Kawasaki] I509 HF, unspecified AMI, acute myocardial infarction; CVD, cardiovascular disease; I510 Cardiac septal defect, acquired DPC, Diagnostic Procedure Combination; HF, heart failure; JROAD, Japanese Registry Of All cardiac and vascular Diseases; NSTEMI, I511 Rupture of chordae tendineae, not elsewhere non-ST elevation myocardial infarction; STEMI, ST elevation classified myocardial infarction. Circulation Journal Vol.80, November 2016 Table S2. Procedure Codes for Data Extraction in JROAD-DPC K code Claim code Procedures K546 150153910 Percutaneous transluminal coronary angioplasty K5481 150284310 Percutaneous transluminal coronary angioplasty (rotablational atherectomy) K5482 150359310 Percutaneous transluminal coronary angioplasty (eximer laser) K549 150263310 PCI with stent implantation K550 160107550 Intracoronary thrombolysis K5521 150145910 CABG (1 anastomosis) K5522 150146010 CABG (>2 anastomoses) K552-21 150318410 Off-pump coronary artery bypass (1 anastomosis) K552-22 150318510 Off-pump coronary artery bypass (>2 anastomoses) K5541 150141010 Valvuloplasty (1 valve) K5542 150279510 Valvuloplasty (2 valves) K5543 150279610 Valvuloplasty (3 valves) K5551 150141410 Valve replacement (1 valve) K5552 150141610 Valve replacement (2 valves) K5553 150141710 Valve replacement (3 valves) K556-2 150260050 Transcatheter aortic valve implantation K559 150139310 Closed mitral commissurotomy K5601 150245010 Aortic
Load more

Recommended publications
  • Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 3054 Date: August 29, 2014 Change Request 8803
    Department of Health & CMS Manual System Human Services (DHHS) Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 3054 Date: August 29, 2014 Change Request 8803 SUBJECT: Ventricular Assist Devices for Bridge-to-Transplant and Destination Therapy I. SUMMARY OF CHANGES: This Change Request (CR) is effective for claims with dates of service on and after October 30, 2013; contractors shall pay claims for Ventricular Assist Devices as destination therapy using the criteria in Pub. 100-03, part 1, section 20.9.1, and Pub. 100-04, Chapter 32, sec. 320. EFFECTIVE DATE: October 30, 2013 *Unless otherwise specified, the effective date is the date of service. IMPLEMENTATION DATE: September 30, 2014 Disclaimer for manual changes only: The revision date and transmittal number apply only to red italicized material. Any other material was previously published and remains unchanged. However, if this revision contains a table of contents, you will receive the new/revised information only, and not the entire table of contents. II. CHANGES IN MANUAL INSTRUCTIONS: (N/A if manual is not updated) R=REVISED, N=NEW, D=DELETED-Only One Per Row. R/N/D CHAPTER / SECTION / SUBSECTION / TITLE D 3/90.2.1/Artifiical Hearts and Related Devices R 32/Table of Contents N 32/320/Artificial Hearts and Related Devices N 32/320.1/Coding Requirements for Furnished Before May 1, 2008 N 32/320.2/Coding Requirements for Furnished After May 1, 2008 N 32/320.3/ Ventricular Assist Devices N 32/320.3.1/Postcardiotomy N 32/320.3.2/Bridge-To -Transplantation (BTT) N 32/320.3.3/Destination Therapy (DT) N 32/320.3.4/ Other N 32/320.4/ Replacement Accessories and Supplies for External Ventricular Assist Devices or Any Ventricular Assist Device (VAD) III.
    [Show full text]
  • A Case of Stenosis of Mitral and Tricuspid Valves in Pregnancy, Treated by Percutaneous Sequential Balloon Valvotomy
    Case Report Annals of Clinical Medicine and Research Published: 30 Jun, 2020 A Case of Stenosis of Mitral and Tricuspid Valves in Pregnancy, Treated by Percutaneous Sequential Balloon Valvotomy Vipul Malpani, Mohan Nair*, Pritam Kitey, Amitabh Yaduvanshi, Vikas Kataria and Gautam Singal Department of Cardiology, Holy Family Hospital, New Delhi, India Abstract Rheumatic mitral stenosis is associated with other lesions, but combination of mitral stenosis and tricuspid stenosis is unusual. We are reporting a case of mitral and tricuspid stenosis in a pregnant lady that was successfully treated by sequential balloon valvuloplasty in a single sitting. Keywords: Mitral stenosis; Tricuspid stenosis; Balloon valvotomy Abbreviations MS: Mitral Stenosis; TS: Tricuspid Stenosis; BMV: Balloon Mitral Valvotomy; CMV: Closed Mitral Valvotomy; BTV: Balloon Tricuspid Valvotomy; PHT: Pressure Half Time; MVA: Mitral Valve Area; TVA: Tricuspid Valve Area; LA: Left Atrium; RA: Right Atrium; TR: Tricuspid Regurgitation Introduction Rheumatic Tricuspid valve Stenosis (TS) is rare, and it generally accompanies mitral valve disease [1]. TS is found in 15% cases of rheumatic heart disease but it is of clinical significance in only 5% cases [2]. Isolated TS accounts for about 2.4% of all cases of organic tricuspid valve disease and is mostly seen in young women [3,4]. Combined stenosis of mitral and tricuspid valves is extremely uncommon. Combined stenosis of both the valves has never been reported in pregnancy. Balloon Mitral Valvotomy (BMV) and surgical Closed Mitral Valvotomy (CMV) are two important OPEN ACCESS therapeutic options in the management of rheumatic mitral stenosis. Significant stenosis of the *Correspondence: tricuspid valve can also be treated by Balloon Tricuspid Valvotomy (BTV) [5,6].
    [Show full text]
  • Severe Tricuspid Valve Stenosis
    Severe Tricuspid Valve Stenosis A Cause of Silent Mitral Stenosis Abdolhamid SHEIKHZADEH, M.D., Homayoon MOGHBELI, M.D., Parviz GHABUSSI, M.D., and Siavosh TARBIAT, M.D. SUMMARY The diastolic rumbling murmur of mitral stenosis (MS) may be attenuated in the presence of low cardiac output, right ventri- cular enlargement, Lutembacher's syndrome, pulmonary emphy- sema, and obesity. In this report we would like to stress that the presence of tricuspid stenosis (TS) is an additional significant cause of silent MS. The clinical material consisted of 73 patients with rheumatic TS who had undergone cardiac surgery. Five of these cases had clinical findings of TS without auscultatory findings of MS. They were found to have severe MS at the time of operation and to re- quire mitral valve surgery. At cardiac catheterization the mean diastolic gradient (MDG) across the mitral valve (MV) was less than 3mmHg and pulmonary arterial systolic pressure was 29- 42mmHg. The MDG across the tricuspid valve was 6-17mmHg. In conclusion, TS can mask clinical and hemodynamic find- ings of MS. The reason for this is the mechanical barrier imposed by TS proximal to the MV. Additional Indexing Words: Rheumatic valvular disease Atrial imprint Tricuspid valve surgery HE most common silent valvular lesion is that of mitral stenosis (MS).1) T The auscultatory findings of MS particularly the diastolic rumble, can be masked in patients with low cardiac output,2) severe pulmonary hyperten- sion right ventricular hypertrophy,3) Lutembacher's syndrome,4) pulmonary emphysema, and obesity.2) The purpose of this communication is to report another cause of true silent MS.
    [Show full text]
  • Building Blocks of Clinical Practice Helping Athletic Trainers Build a Strong Foundation Issue #7: Cardiac Assessment: Basic Cardiac Auscultation Part 2 of 2
    Building Blocks of Clinical Practice Helping Athletic Trainers Build a Strong Foundation Issue #7: Cardiac Assessment: Basic Cardiac Auscultation Part 2 of 2 AUSCULTATION Indications for Cardiac Auscultation • History of syncope, dizziness • Chest pain, pressure or dyspnea during or after activity / exercise • Possible indication of hypertrophic cardiomyopathy • Sensations of heart palpitations • Tachycardia or bradycardia • Sustained hypertension and/or hypercholesterolemia • History of heart murmur or heart infection • Noted cyanosis • Trauma to the chest • Signs of Marfan’s syndrome * Enlarged or bulging aorta * Ectomorphic, scoliosis or kyphosis, pectus excavatum or pectus carinatum * Severe myopia Stethoscope • Diaphragm – best for hearing high pitched sounds • Bell – best for hearing low pitched sounds • Ideally, auscultate directly on skin, not over clothes Adult Rate • > 100 bpm = tachycardia • 60-100 bpm = normal (60-95 for children 6-12 years old) • < 60 bpm = bradycardia Rhythm • Regular • Irregular – regularly irregular or “irregularly” irregular Auscultation Sites / Valvular Positions (see part 1 of 2 for more information) • Aortic: 2nd right intercostal space • Pulmonic: 2nd left intercostal space • Tricuspid: 4th left intercostal space • Mitral: Apex, 5th intercostal space (mid-clavicular line) Auscultate at each valvular area with bell and diaphragm and assess the following: • Cardiac rhythm – regular or irregular • Heart sounds – note the quality • Murmurs – valvular locations • Extra-Cardiac Sounds – clicks, snaps and
    [Show full text]
  • Cardiovascular Magnetic Resonance (CMR) Page 1 of 11
    Cardiovascular Magnetic Resonance (CMR) Page 1 of 11 No review or update is scheduled on this Medical Policy as it is unlikely that further published literature would change the policy position. If there are questions about coverage of this service, please contact Blue Cross and Blue Shield of Kansas customer service, your professional or institutional relations representative, or submit a predetermination request. Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cardiovascular Magnetic Resonance (CMR) Professional Institutional Original Effective Date: August 4, 2005 Original Effective Date: July 1, 2006 Revision Date(s): February 27, 2006, Revision Date(s): May 2, 2007; May 2, 2007; November 1, 2007; November 1, 2007; January 1, 2010; January 1, 2010; February 15, 2013; February 15, 2013; December 11, 2013; December 11, 2013; April 15, 2014; April 15, 2014; July 15, 2014; June 10, 2015; July 15, 2014; June 10, 2015; June 8, 2016; June 8, 2016; October 1, 2016; October 1, 2016; May 10, 2017; May 10, 2017; April 25, 2018; April 25, 2018; October 1, 2018 October 1, 2018 Current Effective Date: July 15, 2014 Current Effective Date: July 15, 2014 Archived Date: July 3, 2019 Archived Date: July 3, 2019 State and Federal mandates and health plan member contract language, including specific provisions/exclusions, take precedence over Medical Policy and must be considered first in determining eligibility for coverage. To verify a member's benefits, contact Blue Cross and Blue Shield of Kansas Customer Service. The BCBSKS Medical Policies contained herein are for informational purposes and apply only to members who have health insurance through BCBSKS or who are covered by a self-insured group plan administered by BCBSKS.
    [Show full text]
  • Surgical Management of Tricuspid Stenosis
    Art of Operative Techniques Surgical management of tricuspid stenosis Marisa Cevasco, Prem S. Shekar Division of Cardiac Surgery, Brigham and Women’s Hospital, Boston, MA, USA Correspondence to: Prem S. Shekar, MD. Chief of Cardiac Surgery, 75 Francis Street, Boston, MA 02115, USA. Email: [email protected]. Tricuspid valve stenosis (TS) is rare, affecting less than 1% of patients in developed nations and approximately 3% of patients worldwide. Detection requires careful evaluation, as it is almost always associated with left-sided valve lesions that may obscure its significance. Primary TS is most frequently caused by rheumatic valvulitis. Other causes include carcinoid, radiation therapy, infective endocarditis, trauma from endomyocardial biopsy or pacemaker placement, or congenital abnormalities. Surgical management of TS is not commonly addressed in standard cardiac texts but is an important topic for the practicing surgeon. This paper will elucidate the anatomy, pathophysiology, and surgical management of TS. Keywords: Tricuspid stenosis (TS); tricuspid valve replacement (TVR) Submitted Feb 26, 2017. Accepted for publication Apr 21, 2017. doi: 10.21037/acs.2017.05.14 View this article at: http://dx.doi.org/10.21037/acs.2017.05.14 Introduction has also been accommodated in the design of annuloplasty rings, which have a gap in the ring in this area. Anatomy The anterior papillary muscle provides chordae to the The tricuspid valve consists of three leaflets (anterior, anterior and posterior leaflets, the posterior papillary muscle posterior, and septal), their associated chordae tendineae provides chordae to the posterior and septal leaflets, and the and papillary muscles, the fibrous tricuspid annulus, and the septal wall gives chordae to the anterior and septal leaflets.
    [Show full text]
  • 2014 AHA/ACC Guideline for the Management of Patients With
    Journal of the American College of Cardiology Vol. 63, No. 22, 2014 Ó 2014 by the American Heart Association, Inc., and the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2014.02.536 PRACTICE GUIDELINE 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons Writing Rick A. Nishimura, MD, MACC, FAHA, Paul Sorajja, MD, FACC, FAHA# Committee Co-Chairy Thoralf M. Sundt III, MD***yy Members* Catherine M. Otto, MD, FACC, FAHA, James D. Thomas, MD, FASE, FACC, FAHAzz Co-Chairy *Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and Robert O. Bonow, MD, MACC, FAHAy other entities may apply; see Appendix 1 for recusal information. yACC/ y AHA representative. zACC/AHA Task Force on Performance Measures Blase A. Carabello, MD, FACC* x { z liaison. ACC/AHA Task Force on Practice Guidelines liaison. Society John P. Erwin III, MD, FACC, FAHA of Cardiovascular Anesthesiologists representative. #Society for Cardio- Robert A. Guyton, MD, FACC*x vascular Angiography and Interventions representative. **American ’ y Association for Thoracic Surgery representative. yySociety of Thoracic Patrick T. O Gara, MD, FACC, FAHA Surgeons representative. zzAmerican Society of Echocardiography Carlos E. Ruiz, MD, PHD, FACCy representative.
    [Show full text]
  • Valve Disease
    The GoToGuide for Valve Disease A helpful resource for patients and caregivers • Valve disease explained • Know the symptoms • Understanding treatment options • Recent FDA approval for expanded use of TAVR • What to expect during treatment Let’s Get Social Stay up to date on heart health and connect with Mended Hearts any time. Find us at www.mendedhearts.org and on these sites: facebook.com/mendedhearts facebook.com/MendedLittleHeartsNationalOrganization @MendedHearts @MLH_CHD Instagram.com/mendedlittleheartsnational The GoToGuide for Valve Disease Valve Disease Explained ..........................2 Know the Symptoms .............................. 8 Understanding Treatment Options ........9 Tools & Resources .................................. 18 Mended Hearts gratefully acknowledges the support of Edwards Lifesciences. mendedhearts.org The GoToGuide for Valve Disease 1 Valve Disease Explained What is Valve Disease? Heart disease is something we’ve all heard about, and for good reason: Right now, it’s the leading cause of death in the United States, killing more than 600,000 Americans every year. (That’s about one out of every four people.) One common form of heart disease is valve disease, which occurs when one or more of your heart valves isn’t working properly. Stenosis vs. Your heart has four valves — the tricuspid, Regurgitation pulmonary, mitral and aortic. Each of these When heart valves valves depends upon tissue flaps that open and become too close every time your heart beats. The flaps narrow for blood make sure blood flows in the right direction to pass through through your heart’s four chambers and to the efficiently, this is rest of your body. called stenosis. However, sometimes certain things interfere The narrowing is with how well the heart valves function.
    [Show full text]
  • Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice
    Please note: Since publication of the 2009 ASE Valve Stenosis Guideline, ASE endorsed the 2014 AHA/ACC Valvular Heart Disease Guidelines (https://www.acc.org/guidelines/hubs/valvular-heart-disease). Descriptions of the stages of mitral stenosis and applicable valve areas in the 2014 AHA/ ACC document are recognized by ASE, and should be used instead of the descriptions and values for mitral stenosis in ASE’s 2009 guideline. GUIDELINES AND STANDARDS Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice Helmut Baumgartner, MD,† Judy Hung, MD,‡ Javier Bermejo, MD, PhD,† John B. Chambers, MD,† Arturo Evangelista, MD,† Brian P. Griffin, MD,‡ Bernard Iung, MD,† Catherine M. Otto, MD,‡ Patricia A. Pellikka, MD,‡ and Miguel Quiñones, MD‡ Abbreviations: AR ϭ aortic regurgitation, AS ϭ aortic stenosis, AVA ϭ aortic valve area, CSA ϭ cross sectional area, CWD ϭ continuous wave Doppler, D ϭ diameter, HOCM ϭ hypertrophic obstructive cardiomyopathy, LV ϭ left ventricle, LVOT ϭ left ventricular outflow tract, MR ϭ mitral regurgitation, MS ϭ mitral stenosis, MVA ϭ mitral valve area, DP ϭ pressure gradient, RV ϭ right ventricle, RVOT ϭ right ventricular outflow tract, SV ϭ ϭ ϭ stroke volume, TEE transesophageal echocardiography, T1/2 pressure half-time, TR ϭ tricuspid regurgitation, TS ϭ tricuspid stenosis, V ϭ velocity, VSD ϭ ventricular septal defect, VTI ϭ velocity time integral I. INTRODUCTION Continuing Medical Education Activity for “Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice” Accreditation Statement: Valve stenosis is a common heart disorder and an important cause of The American Society of Echocardiography is accredited by the Accreditation Council for cardiovascular morbidity and mortality.
    [Show full text]
  • Adult Cardiac Surgery ICD9 to ICD10 Crosswalks ICD-9 Code
    Adult Cardiac Surgery ICD9 to ICD10 Crosswalks ICD-9 Code ICD-9 Description ICD-10 Code ICD-10 Description 164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other C79.89 Secondary malignant neoplasm of other specified specified sites sites 198.89 Secondary malignant neoplasm of other C79.9 Secondary malignant neoplasm of unspecified site specified sites 212.7 Benign neoplasm of heart D15.1 Benign neoplasm of heart 305.1 Tobacco use disorder F17.200 Nicotine dependence, unspecified, uncomplicated 305.1 Tobacco use disorder F17.201 Nicotine dependence, unspecified, in remission 358.00 Myasthenia gravis without (acute) G70.00 Myasthenia gravis without (acute) exacerbation exacerbation 391.0 Acute rheumatic pericarditis I01.0 Acute rheumatic pericarditis 391.1 Acute rheumatic endocarditis I01.1 Acute rheumatic endocarditis 391.2 Acute rheumatic myocarditis I01.2 Acute rheumatic myocarditis 391.8 Other acute rheumatic heart disease I01.8 Other acute rheumatic heart disease 391.9 Acute rheumatic heart disease, unspecified I01.9 Acute rheumatic heart disease, unspecified 393 Chronic rheumatic pericarditis I09.2 Chronic rheumatic pericarditis 394.0 Mitral stenosis I05.0 Rheumatic mitral stenosis 394.1 Rheumatic mitral insufficiency I05.1 Rheumatic mitral insufficiency 394.2 Mitral stenosis with insufficiency I05.2 Rheumatic mitral stenosis with insufficiency 394.9 Other and unspecified mitral valve diseases I05.8 Other
    [Show full text]
  • Giant a Waves Trenton E Burgess,1 André Martin Mansoor2
    Images in… BMJ Case Reports: first published as 10.1136/bcr-2017-221037 on 5 July 2017. Downloaded from Giant a waves Trenton E Burgess,1 André Martin Mansoor2 1Oregon Health and Science DESCRIPTION is a normal feature of the jugular venous waveform University, School of Medicine, A 24-year-old man with a bioprosthetic tricuspid and results from atrial contraction during late dias- Portland, Oregon, USA tole. When there is resistance to atrial emptying, 2 valve related to a history of infective endocarditis Department of Internal secondary to intravenous drug use was admitted such as in tricuspid stenosis, atrial contraction medicine, Oregon Health and to the hospital with fever and dyspnoea over the causes increased back pressure in the venous fluid Science University, Portland, Oregon, USA course of 2–3 weeks in the context of recidivism. column, which manifests as a giant a wave in the On examination, the temperature was 38.0°C and jugular vein. This patient was treated with intra- Correspondence to the respiratory rate 24 breaths per minute. Qual- venous antibiotics but blood cultures remained Dr André Martin Mansoor, itative analysis of the jugular venous waveform positive and clinical deterioration ensued. Valve mansooan@ ohsu. edu revealed the usual components, including two replacement was not offered because of unfavour- peaks, the a and v waves, and two troughs, the x able psychosocial factors and he was discharged Accepted 30 May 2017 and y descents. However, the first peak was more home with hospice support. pronounced than usual, an abnormality known as a giant a wave. These waves coincided with Learning points a late diastolic murmur heard over the left lower sternal border that augmented with inspiration (see ► Qualitative assessment of the jugular venous video 1).
    [Show full text]
  • Incidence and Patterns of Valvular Heart Disease In&Nbsp
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector indian heart journal 66 (2014) 320e326 Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj Original Article Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: A single center experience C.N. Manjunath a, P. Srinivas b,*, K.S. Ravindranath a, C. Dhanalakshmi a a Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, India b PG, Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Jaya Nagar 9th Block, Bannerghatta Road, Bangalore 560069, Karnataka, India article info abstract Article history: Background: Diseases of the heart valves constitute a major cause of cardiovascular Received 4 April 2013 morbidity and mortality worldwide with rheumatic heart disease (RHD) being the domi- Accepted 23 March 2014 nant form of valvular heart disease (VHD) in developing nations. The current study was Available online 14 April 2014 undertaken at a tertiary care cardiac center with the objective of establishing the incidence and patterns of VHD by Echocardiography (Echo). Keywords: Methods: Among the 136,098 first-time Echocardiograms performed between January 2010 Valvular heart disease and December 2012, an exclusion criterion of trivial and functional regurgitant lesions Incidence yielded a total of 13,289 cases of organic valvular heart disease as the study cohort. Echocardiography Results: In RHD, the order of involvement of valves was mitral (60.2%), followed by aortic, Rheumatic heart disease tricuspid and pulmonary valves. Mitral stenosis, predominantly seen in females, was almost exclusively of rheumatic etiology (97.4%).
    [Show full text]